Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Andrew J. Nelson0
Pallavur V. Sivakumar0
Date of Patent
October 2, 2007
0Patent Application Number
109512390
Date Filed
September 27, 2004
0Patent Citations Received
Patent Primary Examiner
Patent abstract
Administration of IL-21 results in decreasing autoimmune responses and thereby provides a beneficial treatment for autoimmune diseases. Specific autoimmune diseases that may be treated include multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, psoriasis, ankylosing spondilitis, scleroderma, Type I diabetes, psoriatic arthritis, osteoarthritis, inflammatory bowel disease, atopic dermatitis and asthma. Pharmaceutical compositions can include IL-21 polypeptides and active fragments thereof.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
